|
US2737518A
(en)
*
|
1955-01-19 |
1956-03-06 |
Schering Corp |
1-hydroxycortisone, 1-hydroxyhydrocortisone and esters thereof
|
|
US2968655A
(en)
*
|
1956-11-23 |
1961-01-17 |
Upjohn Co |
11-oxygenated-6-methyl progesterone and intermediates therefor
|
|
US2920999A
(en)
|
1957-06-07 |
1960-01-12 |
Pfizer & Co C |
21-nitrogen derivatives of corticosteroids
|
|
GB889766A
(en)
|
1958-03-04 |
1962-02-21 |
Olin Mathieson |
Improvements in steroids and the synthesis thereof
|
|
DE1165595B
(de)
|
1958-03-04 |
1964-03-19 |
Olin Mathieson |
Verfahren zur Herstellung von Triamcinolonacetonid-21-hemisuccinat und dessen Salzen
|
|
US3197469A
(en)
|
1958-08-06 |
1965-07-27 |
Pharmaceutical Res Products In |
16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
|
|
US3007923A
(en)
*
|
1959-01-22 |
1961-11-07 |
Lab Francais Chimiotherapie |
Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids
|
|
GB898295A
(en)
|
1959-03-18 |
1962-06-06 |
Upjohn Co |
Improvements in or relating to steroids and the manufacture thereof
|
|
US3033874A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
17beta-propenoyl steroids and process for preparing same
|
|
US3033873A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
21-aminomethyl-pregnenes
|
|
US3020275A
(en)
|
1960-06-07 |
1962-02-06 |
American Cyanamid Co |
21-nitrogen substituted steroids of the pregnane series and methods of preparing the same
|
|
DE1169444B
(de)
*
|
1961-02-22 |
1964-05-06 |
Schering Ag |
Verfahren zur Herstellung von ?-16ª-Methylsteroiden
|
|
US3047468A
(en)
*
|
1961-06-06 |
1962-07-31 |
American Cyanamid Co |
Method of preparing delta1, 4-3-keto steroids of the pregnane series
|
|
US3383394A
(en)
*
|
1965-08-30 |
1968-05-14 |
Schering Corp |
Novel 17-acylating process and products thereof
|
|
US3798216A
(en)
|
1969-03-07 |
1974-03-19 |
Fabrication Des Antibiotique S |
9-fluoro-11beta,21-dihydroxy-16alpha,17-(2-propenylidenedioxy)-pregna-1,4-diene-3,20-dione and derivatives thereof
|
|
DE2047105C3
(de)
|
1970-09-18 |
1979-02-15 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
17-Chlorsteroide und Verfahren zu ihrer Herstellung
|
|
IT1057859B
(it)
|
1972-04-28 |
1982-03-30 |
Sigma Tao Ind Farmaceutiche Sp |
Perivato del triamoinolone
|
|
SE378110B
(enExample)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
SE378109B
(enExample)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
US4076737A
(en)
|
1975-02-20 |
1978-02-28 |
Ciba-Geigy Corporation |
Aldehydes of the pregnane series and derivatives thereof
|
|
IL73337A
(en)
|
1984-10-28 |
1988-09-30 |
Yissum Res Dev Co |
Antitumor steroid-platinum complexes and method for the preparation thereof
|
|
ES8605537A1
(es)
|
1985-07-03 |
1986-02-01 |
Elmu Sa |
Procedimiento de obtencion de cetales ciclicos de corticoi- des y sus 21-c esteres
|
|
SE8604059D0
(sv)
|
1986-09-25 |
1986-09-25 |
Astra Pharma Prod |
A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5116829A
(en)
|
1990-04-23 |
1992-05-26 |
Kao Corporation |
Steroid compounds
|
|
US5183815A
(en)
|
1991-01-22 |
1993-02-02 |
Merck & Co., Inc. |
Bone acting agents
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
CZ171095A3
(en)
|
1993-01-08 |
1996-01-17 |
Astra Ab |
Novel steroidal derivatives specific for colon or ilium
|
|
DE4311987A1
(de)
|
1993-04-07 |
1994-10-13 |
Schering Ag |
Neue Glucocorticoide
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
US5837698A
(en)
|
1996-05-02 |
1998-11-17 |
G. D. Searle & Co. |
Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
|
|
AU3703900A
(en)
|
1999-02-24 |
2000-09-14 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
SE0101220D0
(sv)
|
2001-04-04 |
2001-04-04 |
Astrazeneca Ab |
New use
|
|
US6908934B2
(en)
|
2001-06-11 |
2005-06-21 |
Merck & Co., Inc. |
Therapeutic compounds for treating dyslipidemic conditions
|
|
ITMI20020148A1
(it)
|
2002-01-29 |
2003-07-29 |
Nicox Sa |
Nuovi corticosteroidi
|
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
|
ES2369542T3
(es)
|
2002-07-31 |
2011-12-01 |
Seattle Genetics, Inc. |
Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
EP1562627A4
(en)
|
2002-08-23 |
2006-11-02 |
Mclean Hospital Corp |
CORTICOSTEROID CONJUGATES AND ITS USES
|
|
KR20140070676A
(ko)
|
2002-09-06 |
2014-06-10 |
인설트 테라페틱스, 인코퍼레이티드 |
공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
|
|
CN1414008A
(zh)
*
|
2002-10-17 |
2003-04-30 |
南开大学 |
含氮甾体化合物及其制备方法
|
|
US7015349B2
(en)
|
2003-03-26 |
2006-03-21 |
The Gillette Company |
Reduction of hair growth
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
WO2005063777A1
(en)
|
2003-12-23 |
2005-07-14 |
Corus Pharma |
Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
|
|
US8101714B2
(en)
|
2004-02-18 |
2012-01-24 |
The University Of Georgia Research Foundation, Inc. |
Teleost derived antimicrobial polypeptides
|
|
US20050192257A1
(en)
|
2004-02-26 |
2005-09-01 |
Peyman Gholam A. |
Predictors for patients at risk for glaucoma from steroid therapy
|
|
TW200539855A
(en)
|
2004-03-15 |
2005-12-16 |
Wyeth Corp |
Calicheamicin conjugates
|
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
EP1602931A1
(en)
|
2004-06-03 |
2005-12-07 |
Universiteit Leiden |
SR-A antagonists
|
|
US7541330B2
(en)
|
2004-06-15 |
2009-06-02 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
EP1625854B1
(en)
|
2004-08-09 |
2008-10-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Albumin conjugates containing a glucuronic linker
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
US20080305044A1
(en)
|
2004-11-29 |
2008-12-11 |
Seattle Genetics, Inc. |
Engineered Antibodies and Immunoconjugates
|
|
WO2006135371A1
(en)
|
2005-06-09 |
2006-12-21 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
AU2006259604A1
(en)
|
2005-06-14 |
2006-12-28 |
Gilead Sciences, Inc. |
Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction
|
|
WO2007056181A2
(en)
|
2005-11-02 |
2007-05-18 |
Sicor, Inc. |
Process for the preparation of ciclesonide
|
|
PT1977252E
(pt)
|
2005-12-22 |
2013-01-28 |
Baxter Int |
Teste de activação de monócitos melhorado mais capaz de detectar contaminantes pirogénicos sem serem endotoxinas em produtos médicos
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
WO2008127347A1
(en)
|
2006-07-21 |
2008-10-23 |
Diadexus, Inc. |
Pro115 antibody compositions and methods of use
|
|
MX2009008334A
(es)
|
2007-02-05 |
2009-08-12 |
Nicox Sa |
Esteroides que liberan oxido nitrico.
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
US7985557B2
(en)
|
2007-05-23 |
2011-07-26 |
Ventana Medical Systems, Inc. |
Polymeric carriers for immunohistochemistry and in situ hybridization
|
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
|
CA2692021A1
(en)
|
2007-06-28 |
2008-12-31 |
Capsutech Ltd |
Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers
|
|
CN101397328A
(zh)
|
2007-09-27 |
2009-04-01 |
天津药业研究院有限公司 |
一氧化氮供体型糖皮质激素
|
|
EP2214646B1
(en)
|
2007-10-05 |
2021-06-23 |
Wayne State University |
Dendrimers for sustained release of compounds
|
|
US20110262368A1
(en)
|
2007-12-21 |
2011-10-27 |
Schering Corporation |
C21 thioethers as glucocorticoid receptor agonists
|
|
CN101970452A
(zh)
*
|
2007-12-21 |
2011-02-09 |
先灵公司 |
C20-c21取代的糖皮质激素受体激动剂
|
|
UA108598C2
(xx)
|
2008-04-30 |
2015-05-25 |
|
Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
|
|
EP2294077A1
(en)
|
2008-06-10 |
2011-03-16 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
ES2560807T3
(es)
|
2008-07-21 |
2016-02-22 |
Polytherics Limited |
Nuevos reactivos y procedimiento de conjugación de moléculas biológicas
|
|
US9034325B2
(en)
|
2008-07-22 |
2015-05-19 |
Ablynx N.V. |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
ES2471145T3
(es)
|
2009-03-09 |
2014-06-25 |
Mikasa Seiyaku Co,. Ltd. |
Compuesto esteroide
|
|
WO2010126953A1
(en)
|
2009-04-29 |
2010-11-04 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
WO2010132743A1
(en)
|
2009-05-15 |
2010-11-18 |
Gilead Sciences, Inc. |
Corticosteroid beta-agonist compounds for use in therapy
|
|
DK2889624T3
(en)
|
2009-08-10 |
2018-12-10 |
Ucl Business Plc |
Reversible covalent bonding of functional molecules
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
GB0917044D0
(en)
|
2009-09-29 |
2009-11-18 |
Cytoguide As |
Agents, uses and methods
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
WO2011090940A1
(en)
|
2010-01-19 |
2011-07-28 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
WO2011103389A1
(en)
|
2010-02-19 |
2011-08-25 |
Cornell University |
Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
|
|
PT2528625E
(pt)
|
2010-04-15 |
2013-10-17 |
Spirogen Sarl |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
US20130244905A1
(en)
|
2010-07-06 |
2013-09-19 |
Ed Grabczyk |
Reporter for RNA Polymerase II Termination
|
|
US9023858B2
(en)
|
2010-07-23 |
2015-05-05 |
Takeda Pharmaceutical Company Limited |
Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors
|
|
EP2601298B1
(en)
|
2010-08-02 |
2016-11-30 |
Regeneron Pharmaceuticals, Inc. |
Mice that make binding proteins comprising vl domains
|
|
EP2611785B1
(de)
|
2010-09-01 |
2014-06-04 |
Bayer Intellectual Property GmbH |
N-(tetrazol-5-yl)- und n-(triazol-5-yl)arylcarbonsäureamide und ihre verwendung als herbizide
|
|
JP5828902B2
(ja)
|
2010-10-29 |
2015-12-09 |
イミュノジェン， インコーポレイテッド |
非拮抗性ｅｇｆｒ結合分子およびその免疫複合体
|
|
US20120302505A1
(en)
|
2011-04-21 |
2012-11-29 |
Fetzer Oliver S |
Cyclodextrin-based polymers for therapeutic delivery
|
|
DK2714685T3
(en)
|
2011-05-27 |
2017-01-09 |
Ambrx Inc |
FORMATIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID BOUND dolastatin
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
JP6166728B2
(ja)
|
2011-10-14 |
2017-07-19 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピンの製造に有用な合成方法及び中間体
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
CA2850375C
(en)
|
2011-10-14 |
2019-07-02 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
AU2012322934B2
(en)
|
2011-10-14 |
2016-09-08 |
Medimmune Limited |
Pyrrolobenzodiazepines
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
BR112014013526A8
(pt)
|
2011-12-05 |
2017-06-13 |
Igenica Biotherapeutics Inc |
conjugados de anticorpo-fármaco e compostos, composições e métodos relacionados
|
|
GB201122325D0
(en)
|
2011-12-23 |
2012-02-01 |
Cytoguide As |
Novel formulations
|
|
SG10201704846VA
(en)
|
2012-03-14 |
2017-07-28 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
MX2014015205A
(es)
|
2012-06-14 |
2015-08-14 |
Ambrx Inc |
Anticuerpos anti-psma conjugados a polipeptidos de ligando de receptor nuclear.
|
|
MY186106A
(en)
|
2012-10-11 |
2021-06-22 |
Ascendis Pharma As |
Diagnosis, prevention and treatment of diseases of the joint
|
|
EA201590622A1
(ru)
|
2012-10-16 |
2015-10-30 |
Эндосайт, Инк. |
Конъюгаты для доставки лекарственного средства, содержащие не встречающиеся в природе аминокислоты, и способы применения
|
|
HRP20180268T4
(hr)
|
2012-10-23 |
2026-03-27 |
Synaffix B.V. |
Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu
|
|
WO2014065575A1
(ko)
|
2012-10-25 |
2014-05-01 |
주식회사유한양행 |
4,5-다이하이드로-1h-피라졸 유도체 또는 그의 염 및 이를 포함하는 약학 조성물
|
|
DK2935331T3
(en)
|
2012-12-24 |
2018-06-06 |
Abbvie Inc |
PROLACTIN RECEPTOR BINDING PROTEINS AND APPLICATIONS THEREOF
|
|
HK1220698A1
(zh)
|
2013-03-13 |
2017-05-12 |
Seattle Genetics, Inc. |
环糊精和抗体药物偶联物制剂
|
|
EP2988786A4
(en)
|
2013-04-22 |
2016-12-21 |
Avelas Biosciences Inc |
COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE
|
|
DK2991683T3
(da)
|
2013-05-02 |
2019-11-04 |
Glykos Finland Oy |
Konjugater af et glykoprotein eller en glykan med en toksisk ladning
|
|
US11229711B2
(en)
|
2013-06-06 |
2022-01-25 |
Magenta Therapeutics, Inc. |
Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
KR20160042871A
(ko)
|
2013-06-21 |
2016-04-20 |
이나뜨 파르마, 에스.아. |
폴리펩티드의 효소적 콘쥬게이션
|
|
WO2015005459A1
(ja)
|
2013-07-10 |
2015-01-15 |
生化学工業株式会社 |
呼吸器投与用の医薬組成物
|
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
PT3057585T
(pt)
|
2013-10-15 |
2020-10-21 |
Seagen Inc |
Fármaco-ligadores peguilados para farmacocinética melhorada de conjugados de fármaco-ligando
|
|
GB201320091D0
(en)
|
2013-11-14 |
2014-01-01 |
Univ Manchester |
Selective glucocorticoid receptor ligands
|
|
CN103694375B
(zh)
|
2013-12-13 |
2016-10-05 |
北京大学 |
一种三萜-环糊精共价化合物及其制备方法和用途
|
|
WO2015110609A1
(en)
|
2014-01-24 |
2015-07-30 |
Centre National De La Recherche Scientifique |
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating e. coli induced inflammatory bowel diseases such as crohn's disease
|
|
EP3125943B1
(en)
|
2014-04-04 |
2026-04-22 |
Merck Sharp & Dohme LLC |
Phosphate based linkers for intracellular delivery of drug conjugates
|
|
TWI871999B
(zh)
|
2014-04-10 |
2025-02-01 |
日商第一三共股份有限公司 |
抗her3抗體-藥物結合物
|
|
DK3166638T3
(da)
|
2014-06-13 |
2025-10-06 |
Glykos Finland Oy |
Nyttelagt-polymer-proteinkonjugater
|
|
KR20170086536A
(ko)
|
2014-12-03 |
2017-07-26 |
제넨테크, 인크. |
항-스타필로코커스 아우레우스 항체 리파마이신 접합체 및 이의 용도
|
|
MX2017007231A
(es)
|
2014-12-03 |
2017-11-08 |
Genentech Inc |
Conjugados de rifamicina y anticuerpos contra el staphylococcuss aureus y usos de estos.
|
|
JP2018502839A
(ja)
|
2014-12-09 |
2018-02-01 |
アッヴィ・インコーポレイテッド |
Ｂｃｌ−ｘＬ阻害性化合物およびこれを含む抗体薬物コンジュゲート
|
|
RU2017123942A
(ru)
|
2014-12-09 |
2019-01-11 |
Эббви Инк. |
Ингибирующие bcl-xl соединения, обладающие низкой клеточной проницаемостью, и коньюгаты антитело-лекарственное средство, включающие их
|
|
EP3250211B1
(en)
|
2015-01-30 |
2021-12-22 |
Coral Drugs Pvt. Ltd. |
Novel process for preparation of glucocorticoid steroids
|
|
US20170224835A1
(en)
|
2015-02-06 |
2017-08-10 |
Sorrento Therapeutics, Inc. |
Antibody Drug Conjugates
|
|
JP6993958B2
(ja)
|
2015-07-06 |
2022-02-04 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
多重特異性抗原結合分子およびその使用
|
|
WO2017006279A1
(en)
|
2015-07-08 |
2017-01-12 |
Aten Porus Lifesciences |
Cyclodextrin-polymer complexes and compostions and methods of making and using the same
|
|
CN108135857A
(zh)
|
2015-09-10 |
2018-06-08 |
沙思奇公司 |
生物正交组合物
|
|
WO2017062271A2
(en)
|
2015-10-06 |
2017-04-13 |
Merck Sharp & Dohme Corp. |
Antibody drug conjugate for anti-inflammatory applications
|
|
EP3407916B1
(en)
|
2016-01-29 |
2023-12-20 |
Merck Sharp & Dohme LLC |
Phosphonate linkers and their use to facilitate cellular retention of compounds
|
|
EP3419670A2
(en)
|
2016-02-26 |
2019-01-02 |
Regeneron Pharmaceuticals, Inc. |
Optimized transglutaminase site-specific antibody conjugation
|
|
EP3433278A4
(en)
|
2016-03-25 |
2019-11-06 |
Seattle Genetics, Inc. |
METHOD FOR THE PRODUCTION OF PEGYLATED ACTIVE LINKERS AND INTERMEDIATE PRODUCTS THEREOF
|
|
GB201608936D0
(en)
|
2016-05-20 |
2016-07-06 |
Polytherics Ltd |
Novel conjugates and novel conjugating reagents
|
|
RS62040B1
(sr)
|
2016-06-02 |
2021-07-30 |
Abbvie Inc |
Agonist receptora glukokortikoida i njegovi imunokonjugati
|
|
MX2018015272A
(es)
|
2016-06-08 |
2019-08-12 |
Abbvie Inc |
Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
|
|
KR102520731B1
(ko)
|
2016-09-23 |
2023-04-14 |
리제너론 파아마슈티컬스, 인크. |
항-steap2 항체, 항체-약물 컨쥬게이트, 및 steap2 및 cd3에 결합하는 이중특이적 항원-결합 분자, 및 이의 용도
|
|
CA3042428A1
(en)
|
2016-11-08 |
2018-05-17 |
Regeneron Pharmaceuticals, Inc. |
Steroids and protein-conjugates thereof
|
|
IL298414B2
(en)
|
2017-02-28 |
2024-12-01 |
Immunogen Inc |
Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
|
|
EP3625209A1
(en)
|
2017-05-18 |
2020-03-25 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
KR20250008984A
(ko)
*
|
2017-05-18 |
2025-01-16 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
EP3630189A4
(en)
|
2017-05-24 |
2021-06-23 |
The Board of Regents of The University of Texas System |
LINKER FOR ANTIBODY MEDICINAL CONJUGATES
|
|
CN109106951A
(zh)
|
2017-08-18 |
2019-01-01 |
四川百利药业有限责任公司 |
一种喜树碱-抗体偶联物
|
|
WO2019034177A1
(zh)
|
2017-08-18 |
2019-02-21 |
四川百利药业有限责任公司 |
具有两种不同药物的抗体药物偶联物
|
|
CA3247730A1
(en)
|
2017-11-07 |
2025-10-30 |
Regeneron Pharmaceuticals, Inc. |
Hydrophilic linkers for antibody drug conjugates
|
|
EP3658192B1
(en)
|
2017-12-01 |
2021-04-28 |
AbbVie Inc. |
Glucocorticoid receptor agonist and immunoconjugates thereof
|
|
MA50259A1
(fr)
|
2018-01-08 |
2021-07-29 |
Regeneron Pharma |
Stéroïdes et leurs conjugués-anticorps
|
|
CN111936169A
(zh)
|
2018-04-06 |
2020-11-13 |
西雅图遗传学公司 |
喜树碱肽缀合物
|
|
WO2019217591A1
(en)
|
2018-05-09 |
2019-11-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-msr1 antibodies and methods of use thereof
|
|
CA3120528A1
(en)
|
2018-11-20 |
2020-05-28 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists
|
|
WO2020132483A1
(en)
|
2018-12-21 |
2020-06-25 |
Regeneron Pharmaceuticals, Inc. |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
JP2022517767A
(ja)
|
2019-01-08 |
2022-03-10 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
無痕跡型リンカー及びそのタンパク質－コンジュゲート
|
|
US20230119539A1
(en)
|
2019-01-08 |
2023-04-20 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|
